Oric Pharmaceuticals
ORIC
ORIC
76 hedge funds and large institutions have $98M invested in Oric Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 28
29% less capital invested
Capital invested by funds: $138M → $98M (-$39.6M)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Holders
76
Holding in Top 10
4
Calls
$962K
Puts
$543K
Top Buyers
| 1 | +$3M | |
| 2 | +$2.05M | |
| 3 | +$767K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$560K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$405K |
Top Sellers
| 1 | -$2.69M | |
| 2 | -$2.37M | |
| 3 | -$604K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$556K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$414K |